European stock markets traded without a clear direction on Wednesday, following broadly positive momentum in the previous session as investors weighed fresh economic data and company-specific developments.
The UK’s FTSE 100 was down around 0.6%, while France’s CAC 40 hovered close to flat. Germany’s DAX index, by contrast, advanced roughly 0.7%.
Earlier data from Germany offered mixed signals. Figures showed that the number of people out of work rose by less than expected in December, suggesting some resilience in the labour market. However, German retail sales disappointed, falling 0.6% month on month in November 2025, against expectations for a modest increase.
On the corporate front, shares in Sweden’s Skanska (BIT:1SKAB) moved higher after the construction group completed the sale of a self-developed residential and hotel project in Copenhagen.
German property company LEG Immobilien (TG:LEG) also posted strong gains after confirming the disposal of around 900 residential units for a total value of €63 million during the fourth quarter of 2025.
Meanwhile, wind turbine manufacturer Nordex (TG:NDX1) rallied sharply after being selected to supply more than 414 megawatts of turbines across 15 projects throughout Europe.
In contrast, pharmaceutical group GSK (LSE:GSK) edged lower despite announcing positive Phase III clinical trial results for its hepatitis B candidate bepirovirsen.
Leave a Reply